AUTOIMMUNITY

简称 AUTOIMMUNITY ·ENGLAND ·出版周期 Bimonthly ·年均收录 62 篇

3.1

最新影响因子

6.90%

自引率

较易

投稿难度

较慢,6-12周

审稿周期

期刊简介

《Autoimmunity》是一本专注于自身免疫性疾病研究的国际学术期刊，ISSN号为0891-6934，由英国出版商Taylor & Francis出版，出版地为英国，出版周期为双月刊。该期刊为非开放获取（非OA）期刊，被SCI收录，2022年影响因子为3.4，在中科院分区中通常位于医学大类3区或4区。杂志的发文特点集中于自身免疫性疾病的发病机制、诊断和治疗研究，涵盖类风湿关节炎、系统性红斑狼疮、多发性硬化症等疾病的基础与临床研究。其质量中等，审稿周期相对较短，但近年影响因子波动较小，学术影响力较为稳定；风险在于竞争激烈且接收率较低，对研究创新性和方法学严谨性要求较高，需注意避免低水平重复研究。

影响因子趋势

近期发表

Integrating novel network pharmacology and experimental validation to study the mechanism of Wutou decoction against rheumatoid arthritis 2026-09-16

Reducing glucocorticoid burden in lupus with omega-3 fatty acids: docosahexaenoic acid augments prednisone efficacy in maintaining cyclophosphamide-induced remission of preclinical lupus nephritis 2026-09-14

Transcription factor 12 promotes acute myeloid leukemia cell survival by regulating mitochondrial function and ROS 2026-09-10

Stage-specific ROMO1 in rheumatoid arthritis: predictive immune insights into the MIF pathway and HLA-DR/IL2RA axis via integrated GWAS, transcriptomic, single-cell, and spatial profiling 2026-09-05

Zinc finger protein 24 enhances the pro-inflammatory activities of Tc17 cells and Tc17.1 cells in mouse collagen-induced arthritis 2026-09-03

The m6A reader IGF2BP2 promotes proinflammatory signaling in Lupus nephritis by recognizing STAT1 m6A modifications 2026-09-03

Androgen-associated remodeling of pulmonary NK cells and sex-biased susceptibility in lupus-associated diffuse alveolar hemorrhage 2026-09-03

Targeting IFN signaling as therapeutic option for lupus nephritis 2026-08-26

Interleukin-2 is associated with cytopenias in systemic lupus erythematosus 2026-07-25

Compound kushen injection inhibits immune evasion of hepatocellular carcinoma cells via reducing O-GlcNAcylation of Pd-L1 2026-07-24